Clinical Trial Update: Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a modified non-clarithromycin triple therapy for Helicobacter pylori eradication completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Eradication
• Helicobacter Pylori Infection

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori Eradication Rate | Phase 4 | Status: COMPLETED